Cargando…

Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis

Venous thromboembolisms (VTEs) have been a leading secondary cause of death among ovarian cancer patients, prompting multiple studies of risk factors. The objective of this meta-analysis is to quantify the associations between VTE and the most commonly reported risk factors among ovarian cancer pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weeks, Kristin S., Herbach, Emma, McDonald, Megan, Charlton, Mary, Schweizer, Marin L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486642/ https://www.ncbi.nlm.nih.gov/pubmed/32963543 http://dx.doi.org/10.1155/2020/2374716

Ejemplares similares

Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE
por: Xiong, Wei, et al.
Publicado: (2023)

Patient and Provider Perspectives on Barriers to Accessing Gynecologic Oncologists for Ovarian Cancer Surgical Care
por: Weeks, Kristin, et al.
Publicado: (2020)

Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer
por: Glassman, Deanna, et al.
Publicado: (2022)

Cytoreductive surgery in ovarian cancer
por: Pomel, Christophe, et al.
Publicado: (2007)

Cytoreductive surgery and HIPEC for malignant ascites from colorectal cancer - a randomized study
por: Ba, Mingchen, et al.
Publicado: (2020)

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
por: van der Wall, Sake J., et al.
Publicado: (2018)

VTE risk assessment in pregnancy
por: Ewins, Karl, et al.
Publicado: (2019)

Laparoscopic Cytoreduction for Primary Advanced Ovarian Cancer
por: Fanning, James, et al.
Publicado: (2010)

Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer
por: Lei, Ziying, et al.
Publicado: (2020)

Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer
por: Laios, Alexandros, et al.
Publicado: (2022)

Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer Patients
por: Nieuwenhuyzen-de Boer, Gatske M., et al.
Publicado: (2023)

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)
por: Amin, A., et al.
Publicado: (2009)

Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2016)

Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites
por: Huang, Lin-Lin, et al.
Publicado: (2014)

Ascites—V: The Differential Diagnosis of the Cause of Ascites
Publicado: (1909)

VTE in ICU Patients With COVID-19
por: Moll, Matthew, et al.
Publicado: (2020)

Metabolomic Profile in Venous Thromboembolism (VTE)
por: Franczyk, Beata, et al.
Publicado: (2021)

CLOTTING AND COVID-19: IT IS NOT ALWAYS VTE
por: LINK, STEPHANIE L, et al.
Publicado: (2022)

Mirk kinase inhibition targets ovarian cancer ascites
por: Deng, Xiaobing, et al.
Publicado: (2014)

Comment on ‘Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites’
por: Ahmed, Furqan
Publicado: (2017)

Tertiary cytoreduction in the setting of recurrent ovarian cancer (Review)
por: DOGAN, NASUH UTKU, et al.
Publicado: (2013)

Role of aggressive surgical cytoreduction in advanced ovarian cancer
por: Chang, Suk-Joon, et al.
Publicado: (2015)

Splenectomy during cytoreductive surgery in epithelial ovarian cancer
por: Sun, Hengzi, et al.
Publicado: (2018)

Clinical Utility of Preoperative Assessment in Ovarian Cancer Cytoreduction
por: Koirala, Pratistha, et al.
Publicado: (2020)

Liver Resection as Part of Cytoreductive Surgery for Ovarian Cancer
por: Luna-Abanto, Jorge, et al.
Publicado: (2020)

Trends in extent of surgical cytoreduction for patients with ovarian cancer
por: Wong, Deanna H., et al.
Publicado: (2021)

Predicting incomplete cytoreduction in patients with advanced ovarian cancer
por: Egger, Eva K., et al.
Publicado: (2022)

Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer
por: Son, Joo-Hyuk, et al.
Publicado: (2023)

Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer
por: Certelli, Camilla, et al.
Publicado: (2023)

FIGO staging in ovarian carcinoma and histological subtypes
por: Kehoe, Sean
Publicado: (2020)

Treatment of gestational choriocarcinoma and massive ascites by hypothermic intraperitoneal perfusion chemotherapy guided by ultrasound followed by cytoreductive surgery
por: Ba, Ming-Chen, et al.
Publicado: (2013)

Network of Mediators for Vascular Inflammation and Leakage Is Dysbalanced during Cytoreductive Surgery for Late-Stage Ovarian Cancer
por: Klaschik, Sven, et al.
Publicado: (2019)

Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
por: Bogani, Giorgio, et al.
Publicado: (2018)

Ascites—VII: The Differential Diagnosis of the Cause of Ascites (Continued)
Publicado: (1909)

Ascites—VIII: The Differential Diagnosis of the Cause of Ascites (Continued)
Publicado: (1909)

Ascites—IX: The Differential Diagnosis of the Cause of Ascites (concluded)
Publicado: (1909)

Ascites—VI: The Differential Diagnosis of the Cause of Ascites (Continued)
Publicado: (1909)

The Diagnosis of the Cause of Ascites
Publicado: (1903)

Analysis of Readmissions Due to VTE—Using Hospital Data to Improve VTE Prophylaxis Compliance: A Quality Improvement Project
por: Hussain, Muzamil Hamid, et al.
Publicado: (2023)

Ascitic complement system in ovarian cancer
por: Bjørge, L, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_vec0h4vtknmg72i7c1c4hgi227